drugset
drugset / Trial / NCT04494126

Effect of Perioperative Tranexamic Acid on Blood Loss During Management of Maxillofacial Trauma

NCT04494126 ↗

Phase 4 Unknown 200 enrolled College of Medical Sciences Teaching Hospital. Nepal
RandomizedParallel-groupTriple-blindPrevention

Summary

This is a prospective, randomized, double-blind study investigating whether intravenous tranexamic acid has any effect on blood loss during maxillofacial trauma surgery, or the subsequent postoperative sequelae. Intraoperative bleeding and postoperative ecchymosis and edema are objectively rated and complications are noted.

Timeline

Start
2021-08-15
Primary completion
2021-10-15
Completion
2021-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 10 mg/kg Intravenous
Subject Tranexamic Acid Small molecule 1 g Intravenous

Indications

No indication recorded.